X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-16 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.31 | +50,000 | 11,847,224 | 0% | +$265,630 | ||||||
2024-08-15 | TMCI | Treace James T | Dir | P - Purchase | $5.96 | +84,000 | 1,779,624 | +5% | +$501,035 | ||||||
2024-08-14 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $6.00 | +85,000 | 11,797,224 | +1% | +$510,315 | ||||||
2024-06-11 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.88 | +45,000 | 11,712,224 | 0% | +$264,600 | ||||||
2024-05-31 | TMCI | Treace James T | Dir | P - Purchase | $6.05 | +25,000 | 1,695,624 | +1% | +$151,328 | ||||||
2024-05-29 | TMCI | Treace James T | Dir | P - Purchase | $5.20 | +25,000 | 1,670,624 | +2% | +$130,063 | ||||||
2024-05-28 | TMCI | Treace James T | Dir | P - Purchase | $5.07 | +50,000 | 1,645,624 | +3% | +$253,475 | ||||||
2024-05-22 | TMCI | Mott Richard W | Dir | P - Purchase | $4.99 | +12,100 | 1,054,944 | +1% | +$60,425 | ||||||
2024-05-17 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.56 | +100,000 | 11,667,224 | +1% | +$556,170 | ||||||
2024-05-14 | TMCI | Kiernan Jane E | Dir | P - Purchase | $5.17 | +19,356 | 24,941 | +347% | +$100,001 | ||||||
2024-05-14 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.12 | +150,000 | 11,567,224 | +1% | +$767,805 | ||||||
2024-05-10 | TMCI | Jain Deepti | Dir | P - Purchase | $4.50 | +25,000 | 31,235 | +401% | +$112,568 | ||||||
M | 2024-05-10 | TMCI | Mott Richard W | Dir | P - Purchase | $4.51 | +120,000 | 1,027,753 | +13% | +$540,939 | |||||
M | 2024-05-10 | TMCI | Treace James T | Dir | P - Purchase | $4.54 | +228,000 | 1,595,624 | +17% | +$1,034,004 | |||||
2024-05-10 | TMCI | Bakewell John K | Dir | P - Purchase | $4.57 | +130,000 | 477,348 | +37% | +$594,620 | ||||||
M | 2024-05-10 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $4.57 | +300,000 | 11,417,224 | +3% | +$1,370,370 | |||||
2022-11-15 | TMCI | Treace James T | Dir | S - Sale | $20.29 | -50,000 | 1,592,624 | -3% | -$1,014,692 | ||||||
M | 2023-06-02 | TMCI | Bays F Barry | Former Director | S - Sale | $26.51 | -1,090,821 | 0 | -100% | -$28,917,665 | |||||
D | 2023-05-16 | TMCI | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $25.44 | -25,000 | 32,395 | -44% | -$635,978 | |||||
M | 2023-04-28 | TMCI | Treace James T | Dir | S - Sale | $25.05 | -50,000 | 1,417,624 | -3% | -$1,252,695 | |||||
M | 2023-04-26 | TMCI | Bays F Barry | Dir | S - Sale | $25.47 | -27,804 | 1,090,821 | -2% | -$708,043 | |||||
M | 2023-04-11 | TMCI | Bays F Barry | Dir | S - Sale | $26.27 | -86,160 | 1,118,625 | -7% | -$2,263,499 | |||||
2023-04-06 | TMCI | Mott Richard W | Dir | S - Sale | $26.00 | -4,043 | 905,000 | 0% | -$105,121 | ||||||
M | 2023-04-03 | TMCI | Mott Richard W | Dir | S - Sale | $26.00 | -15,957 | 909,043 | -2% | -$414,893 | |||||
M | 2023-03-30 | TMCI | Mott Richard W | Dir | S - Sale | $25.54 | -133,498 | 925,000 | -13% | -$3,410,027 | |||||
2023-03-30 | TMCI | Treace James T | Dir | S - Sale | $25.86 | -50,000 | 1,467,624 | -3% | -$1,293,170 | ||||||
M | 2023-03-28 | TMCI | Bays F Barry | Dir | S - Sale | $25.16 | -58,698 | 1,204,785 | -5% | -$1,477,075 | |||||
D | 2023-03-15 | TMCI | Owens Daniel E. | Chief Human Resources Officer | S - Sale+OE | $22.87 | -6,250 | 30,914 | -17% | -$142,956 | |||||
2023-03-15 | TMCI | Timbie Thomas E | Dir | S - Sale | $23.03 | -50,000 | 1,513,064 | -3% | -$1,151,665 | ||||||
M | 2023-03-13 | TMCI | Bays F Barry | Dir | S - Sale | $23.70 | -18,800 | 1,263,483 | -1% | -$445,530 | |||||
D | 2023-03-09 | TMCI | Treace John T. | Chief Exec Offer, 10% | S - Sale+OE | $24.41 | -2,075 | 10,945,984 | 0% | -$50,651 | |||||
D | 2023-03-09 | TMCI | Berutti Aaron | SVP, Sales | S - Sale+OE | $24.41 | -733 | 42,842 | -2% | -$17,893 | |||||
D | 2023-03-09 | TMCI | Hair Mark | CFO | S - Sale+OE | $24.41 | -1,040 | 75,335 | -1% | -$25,386 | |||||
D | 2023-03-09 | TMCI | Owens Daniel E. | Chief Human Resources Officer | S - Sale+OE | $24.41 | -411 | 30,914 | -1% | -$10,033 | |||||
D | 2023-03-09 | TMCI | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $24.41 | -505 | 32,395 | -2% | -$12,327 | |||||
D | 2023-03-09 | TMCI | Elder Scot Michael | *See "Remarks" | S - Sale+OE | $24.41 | -177 | 49,921 | 0% | -$4,321 | |||||
M | 2023-03-08 | TMCI | Mott Richard W | Dir | S - Sale | $23.26 | -46,502 | 1,058,498 | -4% | -$1,081,554 | |||||
2023-03-01 | TMCI | Mott Richard W | Dir | S - Sale | $21.35 | -50,000 | 1,105,000 | -4% | -$1,067,545 | ||||||
M | 2023-02-28 | TMCI | Treace James T | Dir | S - Sale | $21.49 | -50,000 | 1,517,624 | -3% | -$1,074,717 | |||||
M | 2023-02-21 | TMCI | Bays F Barry | Dir | S - Sale | $21.86 | -18,800 | 1,282,283 | -1% | -$410,887 | |||||
D | 2023-02-15 | TMCI | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $21.69 | -25,000 | 9,975 | -71% | -$542,235 | |||||
2023-02-15 | TMCI | Timbie Thomas E | Dir | S - Sale | $21.71 | -50,000 | 1,563,064 | -3% | -$1,085,350 | ||||||
M | 2023-02-07 | TMCI | Bays F Barry | Dir | S - Sale | $22.02 | -36,531 | 1,301,083 | -3% | -$804,268 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |